SENP1 and neoplasm: To verify that SENP1 could be a predictor of long-term prognosis in ESCC patients, we used univariate COX regression analysis to validate the patients’ age, gender, lymph node metastasis rate, pathological T-stage, pathological N-stage, tumor differentiation, and SENP1 expression, respectively.